Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Metastasis Colon Cancer × regorafenib × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 15 Carcinoma, Hepatocellular 4 Sarcoma, Ewing 3 Sarcoma 2 Glioblastoma 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Malignant Tumors 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Patient Compliance 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 MSI-H Colorectal Cancer 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Liver Metastasis Colon Cancer 1 Leukemia, Myeloid, Acute 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 HER2-positive Colorectal Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06071052 2026-03-05

DREAM

First Affiliated Hospital, Sun Yat-Sen University

Phase 2 Completed

Gastrointestinal

Liver Metastasis Colon Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡